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Abstract
Background: Bovine tuberculosis (TB) control programs generally rely on the tuberculin skin test (TST) for
ante-mortem detection of Mycobacterium bovis-infected cattle.
Results: Present findings demonstrate that a rapid antibody test based on Dual-Path Platform (DPP®) technology,
when applied 1-3 weeks after TST, detected 9 of 11 and 34 of 52 TST non-reactive yet M. bovis-infected cattle from
the US and GB, respectively. The specificity of the assay ranged from 98.9% (n = 92, US) to 96.0% (n = 50, GB) with
samples from TB-free herds. Multi-antigen print immunoassay (MAPIA) revealed the presence of antibodies to
multiple antigens of M. bovis in sera from TST non-reactors diagnosed with TB.
Conclusions: Thus, use of serologic assays in series with TST can identify a significant number of TST non-reactive
tuberculous cattle for more efficient removal from TB-affected herds.
Keywords: Antibody, Bovine tuberculosis, Dual path platform, Multi-antigen print immunoassay, Tuberculin skin
test, Mycobacterium bovis
Background
Tuberculosis (TB) in humans and animals may result
from exposure to bacilli within the Mycobacterium
tuberculosis complex such as M. tb, M. bovis, M. africa-
num, M. microti, M. caprae, M. orygis, M. suricattae, M.
mungi, or M. canetti [1, 2]. M. bovis is the species most
often isolated from tuberculous cattle. Despite intensive
and costly control efforts over many decades, bovine
TB persists in most countries adversely affecting
animal health, welfare, and trade as well as the liveli-
hoods of producers. Persistence of bovine TB in
livestock populations also demands the maintenance
of costly federal and regional regulatory networks.
Control strategies rely largely on ante-mortem testing
and slaughter inspection to identify livestock herds at
risk. With cattle, the principal ante-mortem tests for
presumptive diagnosis of bovine TB are immunoas-
says that detect cell-mediated responses, including
both in vivo [i.e., tuberculin skin test (TST)] and in
vitro [i.e., interferon gamma release assay (IGRA)]
methods [3–5]. In many countries, TST is applied as
the primary test and IGRA may be used as an
ancillary test in cattle to maximize the number of
infected animals identified or as a confirmatory test
[6]. The most common applications for ante-mortem
testing include routine surveillance to identify M.
bovis-infected herds, test and removal schemes, move-
ment tests, epidemiologic trace-back testing, and in TB-
affected herds to delineate animals going to a slaughter
plant versus being condemned for rendering. While used
extensively for over 100 years in cattle, the TST does have
a number of severe shortcomings. The sensitivity of TST
ranges broadly from 55 to 97% depending on the type and
technical variations of test applied, quality of purified
protein derivative (PPD), environmental exposure/burden
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to atypical mycobacteria, and many other factors [4, 5].
Thus, improved ante-mortem tests and/or testing strat-
egies for bovine TB are greatly needed.
Over the past decade, a new generation of serologic
tests designed to detect antibodies to multiple M. bovis
specific antigens have emerged for application in cattle
[7–13]. Of these, an ELISA using MPB83 and MPB70
antigens (M. bovis Ab Test, IDEXX Laboratories, West-
brook, Maine, US [10]) is approved by the Office Inter-
national des Epizooties and US Department of
Agriculture for discretionary use in cattle; however, ap-
plication of this test has been limited primarily to con-
firmation of infection. Injection of PPDs for TST
significantly boosts antibody responses in M. bovis in-
fected cattle, including animals without prior detectable
antibody responses [10, 11, 14–16]. The enhanced IgG
responses are elicited by M. bovis specific antigens (e.g.,
MPB83 and MPB70) and characterized by accelerated
antibody affinity maturation [17]. The boosted antibody
responses wane beginning ~1-2 months after PPD ad-
ministration; however, they can be further increased
upon PPD re-injection [17]. Despite these advances,
existing antibody assays generally lack diagnostic sensi-
tivity, especially in early infection, and thus require fur-
ther improvements [4–6].
In the present study, sera from M. bovis-infected cattle
identified as TST non-reactors in naturally-exposed
herds within the US (n = 11) and GB (n = 52) were
evaluated for antibody responses to M. bovis specific
proteins using a next generation immunochromatographic
test based on Dual-Path Platform (DPP®) technology
developed by Chembio Diagnostic Systems, Inc. (Medford,
New York, US) [9]. Findings demonstrate the potential for
use of antibody assays to detect M. bovis infection in TST




Sera (n = 127) from GB were obtained from M. bovis-in-
fected cattle detected during routine surveillance, includ-
ing multiple herds and animals of diverse age, gender,
breed, and management systems. All animals received a
single intradermal comparative cervical test (SICCT) and
of these, 52 animals were SICCT negative, IGRA positive
(blood collected for IGRA and serum ~60 days post-
SICCT) with tuberculous lesions detected postmortem.
The other 75 animals were SICCT positive and not tested
by IGRA (serum collection circa 3 weeks post-SICCT at
the abattoir) with tuberculous lesions upon postmortem
and M. bovis isolated from lesions. Serum samples were
also collected from 50 SICCT negative, IGRA negative
cattle located in a TB-free region of GB.
Texas, US
A cow with tuberculous lesions (later confirmed as M.
bovis upon mycobacterial culture) was detected upon
routine inspection at an abattoir in 2014. The source
herd of this cow was determined to consist of approxi-
mately 11,000 Holstein dairy cattle. On postmortem
examination of initial caudal-fold tuberculin test (CFT)
reactors, a tuberculous lesion rate (confirmed by histo-
pathology) of 1.5% was found. Based on epidemiologic
risk factors, it was determined by regulatory officials and
dairy management that destocking the dairy would be
the best approach to rid it of M. bovis. A CFT and col-
lection of blood for serological testing was completed
10-15 days prior to postmortem examination at destock-
ing. A 2% overall prevalence of TB (visible tuberculous
lesions confirmed by histopathology) was noted in cattle
among CFT positive (35%) and CFT negative cattle
(0.4%). From the CFT false-negative cattle, 7 serum
samples obtained within 3 weeks after PPD injection
were available for serologic analysis.
Michigan, US
Two cattle herds, one beef and the other dairy (mostly
Jersey), within the TB-endemic region of Michigan
(Northeast corner of the lower peninsula) were identified
as TB-affected via routine surveillance in 2015. Animals
within these two herds had received CFTs yearly for TB
surveillance prior to 2015. Upon identification of tuber-
culous animals in 2015, CFTs were applied more fre-
quently (~4-6 month interval) in both herds. Based on
the presence of gross lesions upon depopulation, preva-
lence of TB was estimated to be ~21% (17/81) and 9%
(53/561) for the beef and dairy herds, respectively. Four
serum samples collected from M. bovis-infected CFT
non-reactors within 3 weeks after the last CFT adminis-
tration were available for serologic testing.
Multi-antigen print immunoassay (MAPIA)
MAPIA was performed as described previously [18].
Briefly, a panel of ten M. tuberculosis-complex antigens
immobilized on nitrocellulose membrane included
ESAT-6 (Rv3875), CFP10 (Rv3874), MPB64 (Rv1980c),
MPB70 (Rv2875), MPB83 (Rv2873), CFP10/ ESAT-6 fu-
sion protein, MPB70/MPB83 fusion protein, MPB70/
CFP10/Rv0934 fusion protein, bovine PPD (bPPD), and
M. bovis culture filtrate (MBCF). Strips were cut and
blocked with 1% nonfat milk in PBS with 0.05% Tween
20 for 1 h prior to incubation with serum samples di-
luted 1:40 in blocking solution for 1 h. After washing,
strips were incubated with peroxidase-conjugated
Protein G (Sigma, St. Louis, MO) diluted 1:1000 for 1 h,
washed, and developed with 3,3′,5,5′-tetramethyl
benzidine (TMB) (Kirkegaard & Perry Laboratories, Inc.,
Gaithersburg, MD).
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Dual-path platform (DPP®) assay
Bovine IgG and IgM antibodies to CFP10/ESAT-6 and
MPB70/MPB83 protein fusions were detected as
described previously [17] using goat anti-bovine IgG and
anti-bovine IgM antibodies (Kirkegaard & Perry Labora-
tories Inc.) conjugated to colloidal gold nanoparticles by
Chembio standard procedure. Sera were diluted 1:20 in
sample buffer for testing by DPP assay and results were
recorded at 15 min using an optical reader to measure
test band reflectance in relative light units (RLU), as
previously described [17]. Using pre-established cut-
off values of 20 RLU for CFP10/ESAT-6 antigen and
40 RLU for MPB70/MPB83 antigen (same for both
IgM and IgG antibody detection), DPP assay readouts
were expressed as signal-to-cutoff ratios, with any
values ≥1.00 being interpreted as a reactive result and
any value <1.00 being considered as a non-reactive
result.
Data analysis
Diagnostic performance of the serologic assays was
assessed against the gold standard of M. bovis culture
and/or IS-6110 PCR by calculating test sensitivity and
specificity using available software [19] and presented
with the 95% confidence intervals (CI). Fisher’s exact test
was used for analysis of antigen recognition by bovine
antibodies in the present study.
Results
Antibody detection in TST non-reactors versus TST
reactors: Samples from Great Britain
With sera from M. bovis infected cattle in GB, the over-
all IgG reactivity rates in the DPP assay were similar for
SICCT reactors (60%, n = 75) and non-reactors (65.4%,
n = 52). The DPP assay specificity assessed with sera
from 50 SICCT negative, IGRA negative cattle from TB
non-endemic regions of GB was 96% (Table 1). Of note,
the response rate by M. bovis-infected cattle to each
fusion antigen differed significantly (p < 0.01, Fisher’s
exact test) based on TST reactivity. The ratio of MPB70/
MPB83 to CFP10/ESAT-6 reactivity was approximately
3.6:1 for TST reactors versus 1:1 for TST non-reactors
(Table 1). In line with the above, only 1 of 75 TST
reactors but 13 of 52 TST non-reactors produced anti-
body solely to CFP10/ESAT-6 yet not to MPB70/
MPB83. Thus, the immunodominance of serologically
related MPB70 and/or MPB83 proteins typically de-
tected in M. bovis infected cattle after PPD administra-
tion for SICCT was less evident with TST non-reactors,
as reactivity rates to CFP10/ESAT-6 and MPB70/MPB83
were essentially equivalent, and there were considerably
more CFP10/ESAT-6 antibody responders within the
TST non-reactor subset. This observation demonstrates
the potential value for use of additional antigens to
maximize the sensitivity of serologic tests, particularly
with TST non-reactors.
Antibody detection in TST non-reactors: Opportunistic
samples from the United States
During 2015 – 2016, two herds from disparate regions
of the US were under-going whole herd depopulation
due to M. bovis infection within the herds. Antemortem
testing was used to delineate animals going to a slaugh-
ter plant (test negative) versus being condemned for
rendering (test positive). Serum samples were available
for serologic analysis from 11 CFT non-reactive adult
cows with gross tuberculous lesions from the two herds
[Texas (n = 7) and Michigan (n = 4)]. Infection was con-
firmed in these animals by histopathology, mycobacterial
culture, and/or IS-6110 PCR (Table 2). Each of the ani-
mals had received a CFT ~6 months prior to the non-
reactive CFT; of which 4/7 (Texas) and 0/4 (Michigan)
were reactive at that earlier time point, thus indicating
TST reversion in four of the animals. Serum samples
collected ~1-3 weeks after the last CFT were tested with
the DPP assay for the presence of IgM and IgG anti-
bodies to CFP10/ESAT-6 and MPB70/MPB83. Only 4/
11 animals had IgM to MPB70/MPB83, whereas none
produced IgM to CFP10/ESAT-6. In contrast, relatively
potent IgG responses were elicited by MPB70/MPB83
and CFP10/ESAT-6 in 8/11 and 3/11 animals, respect-
ively (Table 3). IgM readouts were generally lower than
those obtained for IgG, suggesting little added value
of IgM antibody detection from a serodiagnostic
sensitivity perspective. The one exception was with
animal #364 which had a high IgM and a borderline
Table 1 IgG reactivity rates in tuberculin skin test reactors and non-reactors found among M. bovis-infected cattle in GB
Animal groupa No. of animals Individual antigen reactivity rates in DPP assayb DPP assay reactivity rateb
(%, 95% CI)CFP10/ESAT-6 MPB70/MPB83
M. bovis infected, TST Reactors 75 12 (16%) 43 (57.3%) 45 (60%; 95% CI: 48,71.2)
M. bovis infected, TST Non-Reactors 52 21 (40.4%) 21 (40.4%) 34 (65.4%, 95% CI: 50.9, 78)
Total M. bovis infected 127 33 (26%) 64 (50.4%) 79 (62.2%, 95% CI: 53.2, 70.6)
TB-free, TST Non-Reactors 50 2 (4%) 2 (4%) 2 (4%, 95% CI: 0.5, 13.7)
aSera obtained from animals in multiple herds and of diverse age, gender, breed and management systems
bData are presented as number (percent) positive per group for each antigen or assay
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IgG signal (Table 3). Development of transient IgM
responses early in the course of experimental M.
bovis infection, as well as shortly after TST adminis-
tration, has been demonstrated in previous studies
using different strains of M. bovis [11, 17, 20]. Thus,
the present findings in the US demonstrated antibody
responses to M. bovis antigens in ~82% of TST non-
reactive cattle with confirmed TB. The specificity of
the DPP assay evaluated on 92 samples from TB-free
states within the US was 98.9% (95% CI: 94.1, 99.9)
or somewhat higher than that found in GB (96.0%;
95% CI: 86.3, 99.5), although not statistically signifi-
cant (p = 0.3).
Antigen recognition by IgG antibodies in sera from TST
non-responders
Serum samples from the US cattle were also analyzed by
MAPIA to determine antigen recognition patterns. Sera
from 10 of 11 cattle reacted with multiple recombinant
antigens of M. bovis (Fig. 1). The one animal (#855)
which had a negative result in the DPP assay, exhibited
IgG binding only to MBCF in MAPIA. Animal #857,
which was the second DPP non-reactor in this group
(Table 3), displayed in MAPIA weak reactivity with the
two fusion antigens containing MPB70. Based on line in-
tensity, the magnitude of antibody responses and antigen
recognition profiles varied among the animals. The most
reactive antigens included MPB70 and MPB83 proteins,
MPB70/MPB83 and MPB70/CFP10/Rv0934 hybrids, as
well as bPPD and MBCF. For M. bovis-infected TST
non-reactors, the role of CFP10/ESAT-6 in eliciting anti-
body responses was not significant in the US (Table 3,
Fig. 1) as compared to the GB set of specimens (Table 1).
Overall, the antigen recognition results supported the
immunodominance of MPB70 and MPB83 proteins in M.
bovis infection of cattle [8, 11, 17, 20].
Table 2 Diagnostic characterization of TST false-negative cattle identified in US herds infected with M. bovis
State Animal ID # CFTa results Postmortem examination results
Jul-2015 Jan-2016 Gross lesions Histopathology PCRb Culture
TX 755 Pos Neg Present TB compatiblec, IS6110 Posd Neg Neg
272 Pos Neg Present TB compatible Pos NDe
976 Neg Neg Present TB compatible Pos ND
857 Pos Neg Present TB compatible Pos ND
676 Pos Neg Present TB compatible Pos ND
889 Pos Neg Present TB compatible Pos ND
352 Neg Neg Present TB compatible Pos ND
MIf Sep-2015 Jan-2016
855 Neg Neg Present TB compatible ND M. bovis
370 Neg Neg Present TB compatible ND M. bovis
364 Neg Neg Present Not compatible ND M. bovis
May-2015 Oct-2015
809 Neg Neg Present TB compatible ND M. bovis
aCFT, caudal fold test (i.e., intradermal M. bovis PPD injected into the caudal skin fold and response determined by palpation 72 h after injection) was applied <3
wks prior to collection of serum
bPCR, polymerase chain reaction for either M. tb complex IS6110 or 1081 DNA on fresh tissue
cMicroscopic granulomatous lesions consistent with bovine TB and containing acid-fast bacilli
dIS6110 DNA by polymerase chain reaction on formalin-fixed tissue
eND, not done
fAnimals # 855, 370, and 364 were from a beef herd while #809 was from a dairy herd
Table 3 Quantitative measure of IgM and IgG responses
produced by TST false-negative cattle in the US
Animal
ID #
Reactivity in the DPP assaya
CFP10/ESAT-6 MPB70/MPB83
IgM IgG IgM IgG
755 0 0.35 0 6.15
272 0 0 1.15 1.08
976 0 1.50 0.75 7.45
857 0 0 0.15 0
676 0 0 1.48 4.85
889 0 2.05 0 19.15
352 0 0.30 0 5.00
855 0 0 0 0
370 0 0 3.10 14.95
364 0 0.50 6.78 1.58
809 0 14.45 0.55 6.23
aData are presented as signal-to-cutoff ratios with ≥1.00 considered as
antibody reactive results (shown in bold)
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Discussion
A major impediment to the control of bovine TB is the
relatively poor accuracy of current ante-mortem tests
compounded by difficulties in reliably detecting tubercu-
lous lesions and/or the agent in all infected animals
upon slaughter surveillance. TST non-reactive cattle are
particularly problematic when applying test and remove
strategies in TB-affected herds. According to Lepper et
al. [21], “Anergy to tuberculin is defined as the failure of
an animal with visible evidence of tuberculosis to show a
palpable cutaneous delayed hypersensitivity response to
a tuberculin, at the time when the test is read.” Such
TST non-reactive animals, however, may still be re-
sponsive on other cell-mediated (e.g., IGRAs [22, 23])
or antibody detection immunoassays [24, 25]. In general,
TST non-responsiveness is more common in animals
from herds with high within-herd prevalence and in ani-
mals at advanced stages of disease [21, 22]. Desensitization
as a result of repeated short interval application of TSTs
may also lead to reduced TST responses associated with
increased interleukin-10 (IL-10) and decreased IL-1β pro-
duction to TB antigens [26]. Our findings further demon-
strate that certain M. bovis-infected cattle can escape
detection by TST by reverting from reactors to non-
reactors within several months; however, a significant pro-
portion of these animals can be identified by ancillary
tests, such as the antibody tests described herein or IGRA
[27].
In the present study, M. bovis specific antibody was
detected by the DPP assay in ~82% and ~65% of M.
bovis-infected, TST non-reactive cattle from the US and
GB, respectively. As reported previously, an in-house
MPB83-based ELISA detected 9 of 20 (45%) SICCT
non-reactors diagnosed with bovine TB in GB [28]. Simi-
larly, the MPB70/83 antibody reactivity rate in the group
of TST non-reactive cattle in GB was ~40% as demon-
strated by DPP assay (for MPB70/MPB83 antigen test
line only, present study) and also shown independently
by a commercial ELISA (M. bovis Ab Test, IDEXX
Laboratories, Westbrook, Maine) using a cocktail of
MPB70 and MPB83 proteins (unpublished data). Import-
antly, integrating CFP10/ESAT-6 to supplement MPB70/
MPB83 antigen in the DPP assay enhanced the overall
test sensitivity to ~65% in TST non-reactive cattle in
GB, thereby highlighting the added benefit of combining
multiple antigens in serologic assays.
Conclusions
The present findings demonstrate the potential for use
of antibody tests in TB-affected herds to rapidly identify
M. bovis-infected, but TST non-reactive cattle. The DPP
assay may also be considered for use in series with TST
as a movement test, particularly as the assay may be
applied pen-side without the need for laboratory equip-
ment and results are available within 20 min. For ex-
ample, Mexican cattle are required to have a negative
CFT within 60 days of entry into the US. Thus, the DPP
assay could be applied after CFT in Mexico or at the
US/Mexico border as a further safeguard against entry
of M. bovis-infected cattle into the US. For this applica-
tion, given a very low disease prevalence in the large
number of cattle crossing the US border with recent
CFT negative results, a viable serologic assay would need
to have an extremely high specificity (>99.9%) to provide
an acceptable positive predictive value at a low pre-test
probability. In the case of the DPP assay, the target
specificity can be established and validated by having a
cut-off value adjusted to meet this key requirement
without a significant loss of diagnostic sensitivity. Given
the limited number of samples available for the study,
present findings should be considered preliminary and
more extensive studies particularly in other bovine TB
endemic countries are warranted to further verify the
utility of this approach. These studies should also in-
clude sera from cattle infected with non-tuberculous











Neg 755     272     976     857     676    889    352    855    370   364   809
Fig. 1 MAPIA testing of TST non-reactive cattle diagnosed with M. bovis infection in the US. Assay was performed as described in Methods. Anti-
gens printed onto nitrocellulose membrane are shown on the right. Results are presented for sera from a negative control (on the left), 7 animals
from TX, and 4 animals from MI. Animal ID numbers are shown on the bottom (see Table 2 for diagnostic characterization). Visible bands on the
strips indicate the presence of IgG to corresponding antigen(s). Intensity of the bands generally correlates with the antibody level
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kansasii, etc.) to determine the possible interaction of
these mycobacteria on this approach, particularly as in-
jection of PPDs for SICCT in cattle vaccinated with heat
inactivated Johne’s disease vaccine may induce false posi-
tive responses to MPB83/70-based antibody assays [29].
With that said, present findings clearly demonstrate that
use of serologic assays in series with TST can identify a
significant number of TST non-reactive tuberculous cat-
tle for more efficient removal from TB-affected herds.
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